Answers are grounded in this paper and cite their sources.
Introduction This study aimed to identify novel markers of NT1 using between-nap and in-nap features of Multiple Sleep Latency Test (MSLT) recordings. We hypothesized that sleep-wake instability observed in NT1, alongside quantifiable patterns of sleepiness during wakefulness, may contain biomarkers for differentiating NT1 from other hypersomnia disorders between naps. Further, we wanted to explore if NT1 and NT2 MSLT could be distinguished beyond the common presence of a mean sleep latency below 8 minutes and multiple SOREMPs. Methods We analyzed in-between nap periods of MSLT recordings, extracting features describing sleepiness, microsleep patterns, and sleep-stage mixing, in three different sleep centers, based on the hypodensities obtained from U-sleep. 107 features were extracted from 178 patients diagnosed with NT1, NT2, Idiopathic Hypersomnia (IH), and Subjective IH (sIH), most with CSF hypocretin levels available. Second, we trained a model to distinguish NT1 from sIH and to differentiate NT1 from other hypersomnolence disorders, including IH plus NT2. A cross-cohort validation strategy was employed, involving training the model on combinations of two cohorts and validating on the third. Results Analysis indicated an increased probability of REM sleep during between-nap periods in the MSLT of NT1 patients, along with a greater prevalence of sleep stage mixing between REM and N1 sleep stages in microsleep episodes. In distinguishing NT1 from NT2, IH, and Subjective IH using features solely from between-nap periods of the MSLT, sensitivity was 0.72, specificity 0.70, and F1-score 0.62 across three validation cohorts. Distinguishing NT1 versus NT2 with between-nap features resulted in sensitivity 0.75, specificity 0.59 and F1-score 0.66 across three validation cohorts. When using features from the in-nap part of the MSLT, NT1 was distinguished from NT2 with sensitivity of 0.75, specificity of 0.82, and F1-score of 0.78 on average across the three validation cohorts. Conclusion The findings in this study support the hypothesis that NT1 patients exhibit increased sleepiness and sleep stage mixing during wake periods compared to other hypersomnolence disorders. Further, NT1 and NT2 could be partially distinguished using in-nap features, even so these two groups of subjects have positive MSLTs. This work supports the use of new analytical methods in MSLT. Support (if any)
No takes yet. Share an insight, caveat, or question.
Andersen et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: